This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

0:00:00
Introduction
Atul Malhotra (United States)

0:13:00
Global trend in obstructive sleep apnea diagnosis
Mary Ip (Hong Kong)

0:57:30
Health consequences in obstructive sleep apnea
Kristina Kairaitis (Australia)

1:31:00
Question and answer

1:48:00
Positive airway pressure therapy in OSA
Naricha Chirakalwasan (Thailand)

2:28:15
Non-positive airway pressure therapy in OSA
Atul Malhotra (United States)

3:03:15
Question and answer

Course Summary:

Obstructive sleep apnea (OSA) is a highly prevalent disorder. Understanding current epidemiological data is crucial for recognizing the scale of the condition and tailoring interventions. Diagnostic tools, such as polysomnography, home sleep apnea testing (HSAT), and wearable technologies, have improved the identification of OSA, though barriers to diagnosis persist in low-resource settings. Untreated OSA has profound short- and long-term health consequences, including increased risks of cardiovascular and metabolic diseases, as well as cognitive and psychological impairments that degrade quality of life. Current treatment modalities can be divided into positive airway pressure (PAP) therapy and non-PAP therapy. Various PAP modalities, such as CPAP, BPAP, and ASV, accommodate different patient needs, and addressing adherence barriers is vital for successful treatment and enhance treatment efficacy. Beyond PAP therapy, alternative treatments such as oral appliances, positional therapy, weight management, and surgical interventions offer personalized therapy based on patient-specific factors. In summary, after participating in this educational course, the audience will acquire the updated knowledge from comprehensive evidence-based review on diagnosis and management strategies for OSA from global perspectives.

Learning Objectives:

Upon completion of this CME activity, participants will be able to:

· Identify current epidemiological data of OSA and describe the global prevalence of OSA and its variations across different regions, populations, and socioeconomic groups.
· Identify current and emerging diagnostic tools and techniques, including advancements in polysomnography, home sleep apnea testing (HSAT), and wearable technologies
· Compare international guidelines and practices for OSA diagnosis
· Address barriers to diagnose OSA in low-resource settings
· Understand the association between OSA and cancer prevalence
· Identify the impact of OSA on atherosclerosis
· Explore the relationship between OSA and ocular conditions
· Evaluate clinical strategies for managing OSA to mitigate vascular risks
· Identify the types of PAP therapy: differentiate between the various modalities of PAP therapy, including CPAP, APAP, BPAP, AutoBPAP, BPAP-VT, ASV, and their indications
· Implement the modalities to address common barriers to PAP adherence and strategies to improve compliance
· Able to interpret downloaded PAP data and troubleshooting the problems
· Describe alternative treatment to PAP therapy including oral appliances, positional therapy, weight management including the emerging data on GLP-1 receptor agonist, and surgical interventions
· Understand the indications, benefits, and limitations of non-PAP therapy in the management of OSA based on current evidence
· Implement the knowledge to develop treatment strategy for personalized therapy for OSA